Optimizing Antiviral Distribution for Pandemic Influenza
Author Information
Author(s): Dimitrov Nedialko B., Goll Sebastian, Hupert Nathaniel, Pourbohloul Babak, Meyers Lauren Ancel
Primary Institution: University of Texas at Austin
Hypothesis
How can the U.S. antiviral stockpile be optimally distributed during a pandemic to minimize infections?
Conclusion
An aggressive community-based antiviral treatment strategy can effectively slow the transmission of mildly transmissible strains like pH1N1.
Supporting Evidence
- The U.S. government distributed a quarter of the antiviral medications in the Strategic National Stockpile within weeks of the pandemic's start.
- The study suggests that appropriate antiviral treatment may be an effective mitigation strategy during the early stages of future influenza pandemics.
- Optimized strategies depend on the transmissibility of the virus and rates of antiviral uptake and wastage.
Takeaway
This study shows how to best share antiviral medicines during a flu outbreak to help sick people and stop the spread of the virus.
Methodology
The study used a tactical optimization model to analyze the distribution of antiviral medications based on a stochastic network model of influenza transmission.
Limitations
The study did not consider the development of antiviral resistance or the use of antivirals for prophylaxis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website